Journal of Diabetes & Metabolism

ISSN - 2155-6156

Citations Report

Journal of Diabetes & Metabolism : Citations & Metrics Report

Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.

  2024 2023 2022 2021 2020 2019

Total published articles

123 107 59 61 45 23

Research, Review articles and Editorials

44 54 37 40 21 22

Research communications, Review communications, Editorial communications, Case reports and Commentary

5 1 2 5 3 0

Conference proceedings

6 16 5 7 0 45

Citations received as per Google Scholar, other indexing platforms and portals

632 946 1156 1199 1039 1106
Journal total citations count 10648
Journal impact factor 12.50
Journal 5 years impact factor 18.23
Journal cite score 23.62
Journal h-index 43
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important Citations

Ang SH, Thevarajah M, Alias Y, Khor SM. Current aspects in hemoglobin A1c detection: a review. Clinica Chimica Acta. 2015 Jan 15;439:202-11.

Markowicz-Piasecka MJ. ZAŁĄCZNIK NR 2.

Rachana N. Research and Reviews: Research Journal of Biology. prostate.;48:49.

Csaba G. Immunity and longevity. Acta microbiologica et immunologica Hungarica. 2018 Jul 3;66(1):1-7.

Rubio-Ruiz ME, Guarner-Lans V. Inflammation and the use of anti-inflammatory agents in signs and cardiovascular consequences of metabolic syndrome. Handbook on Metabolic syndrome. Classification, risk factors and health impact. New York: Nova Biomedical. 2012:169-88.

Markowicz-Piasecka M, Sikora J, Mateusiak Ł, Mikiciuk-Olasik E, Huttunen KM. New prodrugs of metformin do not influence the overall haemostasis potential and integrity of the erythrocyte membrane. European journal of pharmacology. 2017 Sep 15;811:208-21.

Nayaker BS, Thomas S, Ramachandran S, Loganathan S, Sundari M, Mala K. Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017 Dec 1;11:S841-51.

Markowicz-Piasecka M, M Huttunen K, Mateusiak L, Mikiciuk-Olasik E, Sikora J. Is metformin a perfect drug? Updates in pharmacokinetics and pharmacodynamics. Current pharmaceutical design. 2017 May 1;23(17):2532-50.

Rubio-Ruiz ME, Hafidi ME, Perez-Torres I, Banos G, Guarner V. Medicinal agents and metabolic syndrome. Current medicinal chemistry. 2013 Jul 1;20(21):2626-40.

Mohammed WA, Jasim HM, Salman EN. GENETIC POLYMORPHISM IN ADIPONECTIN GENE IN IRAQI PATIENTS WITH TYPE-II DIABETES MELLITUS.

Nisha K. Diabetes Mellitus: Classification, Symptoms and Management: A Review.

Bains V, Kaur H. Association study of the single‐nucleotide polymorphisms− 3971G/A and+ 276G/T in the adiponectin gene with type 2 diabetes in a North Indian Punjabi population. Annals of human genetics. 2019 Nov 21.

Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011 Dec 25;2(9):1000167.

Manjuladevi K, Rajashanmugam B, Sukhdev R, Krishnan S, Rahini P. A Review on the role of BCG Vaccine in type-1diabetes. International Journal of Research in Pharmaceutical Sciences. 2019 Apr 14;10(2):1103-9.

Vanita P, Jhansi K. Metabolic syndrome in endocrine system. J diabetes Metab. 2011;2(163):2.

Malematja RO, Bagla VP, Njanje I, Mbazima V, Poopedi KW, Mampuru L, Mokgotho MP. Potential Hypoglycaemic and Antiobesity Effects of Senna italica Leaf Acetone Extract. Evidence-Based Complementary and Alternative Medicine. 2018;2018.

Dhanya R, Sinumol G, Nisha P, Lankalapalli RS, Sundaresan A, Arun KB, Jayamurthy P, Anusree SS, Syama HP. Syzygium Cumini Seed Exhibits Antidiabetic Potential via Multiple Pathways Involving Inhibition of α-Glucosidase, DPP-IV, Glycation, and Ameliorating Glucose Uptake in L6 Cell Lines.

Chan B. Ellagic Acid and Urolithin A Improve Insulin Sensitivity in Diet-Induced Insulin Resistant Mice and Reduce Detrimental Effects of Palmitate Administration in Differentiated C2C12 Myotubes (Doctoral dissertation, UCLA).

Butala MA, Kukkupuni SK, Venkatasubramanian P, Vishnuprasad CN. An Ayurvedic Anti‐Diabetic Formulation Made from Curcuma longa L. and Emblica officinalis L. Inhibits α‐Amylase, α‐Glucosidase, and Starch Digestion, In Vitro. Starch‐Stärke. 2018 May;70(5-6):1700182.

Aswathi U, Nisha P, Arun KB, Venugopal VV, Madhavankutty TS. Nutraceutical properties of cumin residue generated from Ayurvedic industries using cell line models.

Top